ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,996.66
1.00%
US Tech 100
20,877.20
1.72%
Dow Jones
43,487.83
0.78%
Brent Oil
80.005
0.00%
Bitcoin
102,942.60
-1.14%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. Azitra Inc (AZTR)

  7. Azitra Inc (AZTR) News

AZTR

Azitra (AZTR)

Azitra Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:AZTR
DateTimeSourceHeadlineSymbolCompany
01/16/20252:12PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AZTRAzitra Inc
01/16/202510:36AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:AZTRAzitra Inc
01/15/20258:30AMPR Newswire (US)Azitra Announces Pricing of $1.5 Million Public Offering of Common StockAMEX:AZTRAzitra Inc
01/14/20255:23PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:AZTRAzitra Inc
01/14/20254:12PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialAMEX:AZTRAzitra Inc
01/14/20254:10PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:AZTRAzitra Inc
01/14/20254:05PMPR Newswire (US)Azitra Announces Proposed Public Offering of Common StockAMEX:AZTRAzitra Inc
11/26/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AZTRAzitra Inc
11/12/20245:05PMPR Newswire (US)Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business UpdatesAMEX:AZTRAzitra Inc
11/12/20245:01PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:AZTRAzitra Inc
10/29/20249:00AMBusiness WireAzitra to Present at BIO-Europe 2024AMEX:AZTRAzitra Inc
10/11/20249:00AMBusiness WireAzitra to Participate in the 2024 Maxim Healthcare Virtual SummitAMEX:AZTRAzitra Inc
10/09/20245:01PMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersAMEX:AZTRAzitra Inc
10/09/20244:55PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:AZTRAzitra Inc
09/24/20248:00AMBusiness WireAzitra, Inc. Announces Late-Breaking Presentation at the European Academy of Dermatology and Venereology CongressAMEX:AZTRAzitra Inc
09/18/20249:00AMBusiness WireAzitra Receives Fast Track Designation for ATR-04 for Skin Rash from EGFR InhibitorsAMEX:AZTRAzitra Inc
09/16/20245:47PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesAMEX:AZTRAzitra Inc
09/06/20244:30PMBusiness WireAzitra to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceAMEX:AZTRAzitra Inc
08/28/20248:30AMBusiness WireAzitra Announces First Patient Dosed in Phase 1b Trial of ATR-12 for Netherton SyndromeAMEX:AZTRAzitra Inc
08/22/20249:00AMBusiness WireAzitra Receives Study May Proceed letter from the FDA for IND to Treat Skin Rash from EGFR InhibitorsAMEX:AZTRAzitra Inc
08/20/20244:15PMBusiness WireAzitra Announces First Patient Screened and Scheduled to Enroll in Phase 1b Trial of ATR-12 for Netherton SyndromeAMEX:AZTRAzitra Inc
08/12/20246:23PMBusiness WireAzitra, Inc. Announces Q2 2024 Financial Results and Provides Business UpdatesAMEX:AZTRAzitra Inc
08/12/20245:15PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AZTRAzitra Inc
08/12/20245:02PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:AZTRAzitra Inc
08/02/20244:05PMEdgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]AMEX:AZTRAzitra Inc
07/29/20244:01PMEdgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsAMEX:AZTRAzitra Inc
07/26/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportAMEX:AZTRAzitra Inc
07/25/20245:57PMBusiness WireCORRECTING and REPLACING Azitra, Inc. Announces Closing of $10.0 Million Public OfferingAMEX:AZTRAzitra Inc
07/25/20242:15PMBusiness WireAzitra, Inc. Announces Closing of Public OfferingAMEX:AZTRAzitra Inc
07/25/20246:03AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:AZTRAzitra Inc
 Showing the most relevant articles for your search:AMEX:AZTR

Your Recent History

LSE
SVM
Svm Uk Emerging
LSE
ING
Ingenta
NASDAQ
BIOT
Biotech Acquisition
LSE
55HZ
Quadgas 3.42%
ASX
XJM
S&P ASX 200 Ex S&P ASX 100
BOV
C2EM34
Cemex Sab de Cv
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads